Friday, Jul 17th
Last update08:07:16 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 One of the strictest abortion bans in the country will be on the ballot this November... |
 Martha Lillard, who contracted polio at age five and spent most of her life dependent on... | ||
 One in four Israelis now engages in harmful substance use as the psychological fallout from Israel’s... |
 New York City’s famed Solomon R Guggenheim Museum was among a number of Manhattan buildings that... |
